Published in Jpn J Clin Oncol on April 08, 2010
Salvage cryotherapy for radiation-recurrent prostate cancer: outcomes and complications. Curr Urol Rep (2011) 0.82
Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer. JAMA (1998) 21.31
The 2005 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma. Am J Surg Pathol (2005) 12.31
Contemporary update of prostate cancer staging nomograms (Partin Tables) for the new millennium. Urology (2001) 3.99
Pelvic lymph node dissection in prostate cancer. Eur Urol (2009) 3.93
Predicting the risk of lymph node involvement using the pre-treatment prostate specific antigen and Gleason score in men with clinically localized prostate cancer. Int J Radiat Oncol Biol Phys (1994) 2.53
The Phoenix definition of biochemical failure predicts for overall survival in patients with prostate cancer. Cancer (2008) 1.98
Review of major adverse effects of androgen-deprivation therapy in men with prostate cancer. Cancer (2009) 1.90
Methods of calculating prostate-specific antigen velocity. Eur Urol (2006) 1.84
Determinants of change in prostate-specific antigen over time and its association with recurrence after external beam radiation therapy for prostate cancer in five large cohorts. Int J Radiat Oncol Biol Phys (2008) 1.63
Increasing external beam dose for T1-T2 prostate cancer: effect on risk groups. Int J Radiat Oncol Biol Phys (2006) 1.62
Risk of prostate carcinoma death in patients with lymph node metastasis. Cancer (2001) 1.58
Role of prostate dose escalation in patients with greater than 15% risk of pelvic lymph node involvement. Int J Radiat Oncol Biol Phys (2005) 1.57
Predicting the risk of pelvic node involvement among men with prostate cancer in the contemporary era. Int J Radiat Oncol Biol Phys (2009) 1.55
Timing of biochemical failure and distant metastatic disease for low-, intermediate-, and high-risk prostate cancer after radiotherapy. Cancer (2007) 1.18
Does hormone treatment added to radiotherapy improve outcome in locally advanced prostate cancer?: meta-analysis of randomized trials. Cancer (2009) 1.13
Sentinel lymph node dissection for prostate cancer: experience with more than 1,000 patients. J Urol (2007) 1.13
Long-term treatment sequelae after external beam irradiation with or without hormonal manipulation for adenocarcinoma of the prostate: analysis of radiation therapy oncology group studies 85-31, 86-10, and 92-02. Int J Radiat Oncol Biol Phys (2007) 1.06
Whole pelvic radiotherapy versus prostate only radiotherapy in the management of locally advanced or aggressive prostate adenocarcinoma. Int J Radiat Oncol Biol Phys (2009) 1.03
External validation of the updated Partin tables in a cohort of North American men. J Urol (2008) 0.95
Moderate dose escalation in three-dimensional conformal localized prostate cancer radiotherapy: single-institutional experience in 398 patients comparing 66 Gy versus 70 Gy versus 74 Gy. Strahlenther Onkol (2009) 0.89
Lack of benefit of pelvic radiation in prostate cancer patients with a high risk of positive pelvic lymph nodes treated with high-dose radiation. Int J Radiat Oncol Biol Phys (2005) 0.88
Why are pretreatment prostate-specific antigen levels and biochemical recurrence poor predictors of prostate cancer survival? Cancer (2009) 0.87
Histopathological characteristics of lymph node metastases predict cancer-specific survival in node-positive prostate cancer. BJU Int (2008) 0.85
Patterns of Care and RTOG studies in prostate cancer: long-term survival, hazard rate observations, and possibilities of cure. Int J Radiat Oncol Biol Phys (1994) 0.85
Prognostic factors in prostate cancer. Analysis of 874 patients treated with radiation therapy. Cancer (1993) 0.83
Indications for pelvic lymphadenectomy in prostate cancer. Urol Clin North Am (2001) 0.83
Partin Tables cannot accurately predict the pathological stage at radical prostatectomy. Eur J Surg Oncol (2008) 0.82
What pretreatment prostate-specific antigen level warrants long-term androgen deprivation? Int J Radiat Oncol Biol Phys (2005) 0.77
Enhancer transcripts mark active estrogen receptor binding sites. Genome Res (2013) 2.82
Ocular surface changes with applanation contact lens and coupling fluid use after argon laser photocoagulation in noninsulin-dependent diabetes mellitus. Am J Ophthalmol (2004) 2.06
The international workshop on meibomian gland dysfunction: report of the definition and classification subcommittee. Invest Ophthalmol Vis Sci (2011) 1.80
New grading system for the evaluation of chronic ocular manifestations in patients with Stevens-Johnson syndrome. Ophthalmology (2007) 1.71
Impact of IGF-I and CYP19 gene polymorphisms on the survival of patients with metastatic prostate cancer. J Clin Oncol (2006) 1.68
Mathematical projection model of visual loss due to fuchs corneal dystrophy. Invest Ophthalmol Vis Sci (2011) 1.53
Cytokeratin 15 can be used to identify the limbal phenotype in normal and diseased ocular surfaces. Invest Ophthalmol Vis Sci (2006) 1.53
The comparison of solitary topical micafungin or fluconazole application in the treatment of Candida fungal keratitis. Br J Ophthalmol (2010) 1.43
Health-related quality of life after carbon-ion radiotherapy for prostate cancer: a 3-year prospective study. Int J Urol (2013) 1.41
Tear function and ocular surface findings in premature and term babies. Ophthalmology (2004) 1.41
Determination of the depth of 50% of maximum ionization, I50, for electron beams by the divided difference method. Med Phys (2004) 1.39
Microkeratome-assisted phacoemulsification. J Cataract Refract Surg (2005) 1.38
Kidney stone disease and risk factors for coronary heart disease. Int J Urol (2005) 1.27
Serum-free spheroid culture of mouse corneal keratocytes. Invest Ophthalmol Vis Sci (2005) 1.20
Carbon-ion radiation therapy for prostate cancer. Int J Urol (2012) 1.13
A randomized trial comparing radical prostatectomy plus endocrine therapy versus external beam radiotherapy plus endocrine therapy for locally advanced prostate cancer: results at median follow-up of 102 months. Jpn J Clin Oncol (2006) 1.13
Development of a nomogram to predict probability of positive initial prostate biopsy among Japanese patients. Urology (2006) 1.13
Low-concentration homogenized castor oil eye drops for noninflamed obstructive meibomian gland dysfunction. Ophthalmology (2002) 1.11
Association between meibomian gland changes and aging, sex, or tear function. Cornea (2006) 1.10
The role of oxidative stress and inflammation in conjunctivochalasis. Invest Ophthalmol Vis Sci (2009) 1.09
The contribution of the posterior surface to the corneal aberrations in eyes after keratoplasty. Invest Ophthalmol Vis Sci (2011) 1.08
Pyogenic psoas abscess: difficulty in early diagnosis. Urol Int (2003) 1.07
Long-term outcome of cultivated oral mucosal epithelial sheet transplantation in treatment of total limbal stem cell deficiency. Ophthalmology (2011) 1.07
Efficacy of a new warm moist air device on tear functions of patients with simple meibomian gland dysfunction. Cornea (2006) 1.07
The impact of nasal conjunctivochalasis on tear functions and ocular surface findings. Am J Ophthalmol (2007) 1.06
Therapeutic deep lamellar keratoplasty for cornea perforation. Am J Ophthalmol (2003) 1.04
Evaluation of lipid oxidative stress status in Sjögren syndrome patients. Invest Ophthalmol Vis Sci (2013) 1.04
The effects of 2 week senofilcon-A silicone hydrogel contact lens daily wear on tear functions and ocular surface health status. Cont Lens Anterior Eye (2010) 1.04
Atopic ocular surface disease: implications on tear function and ocular surface mucins. Cornea (2005) 1.04
Age-related dysfunction of the lacrimal gland and oxidative stress: evidence from the Cu,Zn-superoxide dismutase-1 (Sod1) knockout mice. Am J Pathol (2012) 1.03
Pretreatment serum testosterone level as a predictive factor of pathological stage in localized prostate cancer patients treated with radical prostatectomy. Eur Urol (2004) 1.03
Characteristics of traumatic globe rupture after keratoplasty. Ophthalmology (2009) 1.02
Alternative antiandrogens to treat prostate cancer relapse after initial hormone therapy. J Urol (2004) 1.02
Development of a new nomogram for predicting the probability of a positive initial prostate biopsy in Japanese patients with serum PSA levels less than 10 ng/mL. Int J Urol (2008) 1.01
Complete spontaneous crystalline lens dislocation into the anterior chamber with severe corneal endothelial cell loss. Cornea (2007) 1.00
Comparison of corneal and aqueous humor penetration of moxifloxacin, gatifloxacin and levofloxacin during keratoplasty. Adv Ther (2012) 1.00
Structural insights into Atg10-mediated formation of the autophagy-essential Atg12-Atg5 conjugate. Structure (2012) 1.00
Comparison of deep lamellar keratoplasty and penetrating keratoplasty for lattice and macular corneal dystrophies. Am J Ophthalmol (2006) 0.99
The use of human mesenchymal stem cell-derived feeder cells for the cultivation of transplantable epithelial sheets. Invest Ophthalmol Vis Sci (2009) 0.99
Phenotypic study after cultivated limbal epithelial transplantation for limbal stem cell deficiency. Arch Ophthalmol (2007) 0.98
Spontaneous lacrimal punctal occlusion associated with ocular chronic graft-versus-host disease. Curr Eye Res (2007) 0.96
Melanocytes in the corneal limbus interact with K19-positive basal epithelial cells. Exp Eye Res (2005) 0.96
Tear cytokine and ocular surface alterations following brief passive cigarette smoke exposure. Cytokine (2008) 0.96
Risk factors of late rectal bleeding after carbon ion therapy for prostate cancer. Int J Radiat Oncol Biol Phys (2006) 0.95
Cataract surgery combined with ocular surface reconstruction in patients with severe cicatricial keratoconjunctivitis. J Cataract Refract Surg (2002) 0.95
Endoscopy-guided vitreoretinal surgery following penetrating corneal injury: a case report. Clin Ophthalmol (2010) 0.95
Collagen-immobilized poly(vinyl alcohol) as an artificial cornea scaffold that supports a stratified corneal epithelium. J Biomed Mater Res B Appl Biomater (2006) 0.95
Disposable eyelid-warming device for the treatment of meibomian gland dysfunction. Jpn J Ophthalmol (2003) 0.94
The effects of 2% rebamipide ophthalmic solution on the tear functions and ocular surface of the superoxide dismutase-1 (sod1) knockout mice. Invest Ophthalmol Vis Sci (2013) 0.94
Carbon ion radiotherapy in advanced hypofractionated regimens for prostate cancer: from 20 to 16 fractions. Int J Radiat Oncol Biol Phys (2012) 0.93
Corneal opacity and cataract: triple procedure versus secondary approach. Cornea (2003) 0.93
Effects of diquafosol sodium eye drops on tear film stability in short BUT type of dry eye. Cornea (2013) 0.92
Clinical effect of naftopidil on the quality of life of patients with lower urinary tract symptoms suggestive of benign prostatic hyperplasia: a prospective study. Int J Urol (2010) 0.91
Proliferation and differentiation of transplantable rabbit epithelial sheets engineered with or without an amniotic membrane carrier. Invest Ophthalmol Vis Sci (2007) 0.91
Subepithelial corneal fibrosis partially due to epithelial-mesenchymal transition of ocular surface epithelium. Mol Vis (2010) 0.91
Changes in chromogranin a serum levels during endocrine therapy in metastatic prostate cancer patients. Eur Urol (2005) 0.91
A novel NIH/3T3 duplex feeder system to engineer corneal epithelial sheets with enhanced cytokeratin 15-positive progenitor populations. Tissue Eng Part A (2008) 0.90
Symptoms, visual function, and mucin expression of eyes with tear film instability. Cornea (2013) 0.90
Intermittent androgen suppression for locally advanced and metastatic prostate cancer: preliminary report of a prospective multicenter study. Urology (2004) 0.90
Porous silk fibroin film as a transparent carrier for cultivated corneal epithelial sheets. J Biomater Sci Polym Ed (2011) 0.90
Functional visual acuity in Stevens-Johnson syndrome. Am J Ophthalmol (2006) 0.90
Immunohistochemistry and electron microscopy of retrocorneal scrolls in syphilitic interstitial keratitis. Curr Eye Res (2007) 0.89
Deep lamellar keratoplasty (DLKP) in keratoconus patients using viscoadaptive viscoelastics. Cornea (2005) 0.89
Ocular surface and MUC5AC alterations in atopic patients with corneal shield ulcers. Curr Eye Res (2005) 0.89
[Primary carcinoid tumor of the testis metastatic to the para-aortic lymph nodes in six years after the first operation: a case report]. Hinyokika Kiyo (2009) 0.89
In vivo confocal microscopy evaluation of meibomian gland dysfunction in atopic-keratoconjunctivitis patients. Ophthalmology (2012) 0.89
Lactoferrin in Sjögren's syndrome. Ophthalmology (2007) 0.88
Clinical usefulness of diquafosol for real-world dry eye patients: a prospective, open-label, non-interventional, observational study. Adv Ther (2014) 0.88
Barrier function and cytologic features of the ocular surface epithelium after autologous cultivated oral mucosal epithelial transplantation. Arch Ophthalmol (2008) 0.88
Prognostic factors for corneal graft recovery after severe corneal graft rejection following penetrating keratoplasty. BMC Ophthalmol (2013) 0.87
Phase I/II clinical trials of carbon ion therapy for prostate cancer. Prostate (2004) 0.87
Transplantation of cultivated oral mucosal epithelium prepared in fibrin-coated culture dishes. Invest Ophthalmol Vis Sci (2012) 0.87
Tear film with "Orgahexa EyeMasks" in patients with meibomian gland dysfunction. Optom Vis Sci (2008) 0.87
Infectious keratitis outbreak after laser in situ keratomileusis at a single laser center in Japan. J Cataract Refract Surg (2011) 0.87
Evaluation of conjunctival inflammatory status by confocal scanning laser microscopy and conjunctival brush cytology in patients with atopic keratoconjunctivitis (AKC). Mol Vis (2009) 0.87
Carbon ion radiation therapy for prostate cancer: results of a prospective phase II study. Radiother Oncol (2006) 0.87
Evaluation of tear stability after surgery for conjunctivochalasis. Optom Vis Sci (2011) 0.86
Impact of the descemet membrane perforation on surgical outcomes after deep lamellar keratoplasty. Am J Ophthalmol (2007) 0.86
The impact of the onset time of atopic keratoconjunctivitis on the tear function and ocular surface findings. Am J Ophthalmol (2006) 0.86
Greater growth potential of p63-positive epithelial cell clusters maintained in human limbal epithelial sheets. Invest Ophthalmol Vis Sci (2009) 0.86
Recent advances in cultivated epithelial transplantation. Cornea (2008) 0.86
Lamellar corneal injury by bamboo splinters: a case report. J Med Case Rep (2009) 0.86
N-cadherin in the maintenance of human corneal limbal epithelial progenitor cells in vitro. Invest Ophthalmol Vis Sci (2009) 0.86
Corneal and retinal effects of ultraviolet-B exposure in a soft contact lens mouse model. Invest Ophthalmol Vis Sci (2012) 0.86
Evaluation of lipid oxidative stress status and inflammation in atopic ocular surface disease. Mol Vis (2010) 0.86
[Clinical effects of a 3-month formulation LH-RH agonist, TAP-144-SR (3M) in prostate cancer patients]. Hinyokika Kiyo (2002) 0.86
Outcomes of cataract surgery in eyes with a low corneal endothelial cell density. J Cataract Refract Surg (2011) 0.84
Observations of immuno-gold conjugates on influenza viruses using waveguide-mode sensors. PLoS One (2013) 0.84
Efficacy and safety of dutasteride on prostate cancer risk reduction in Asian men: the results from the REDUCE study. Jpn J Clin Oncol (2010) 0.84
Long-standing bullous keratopathy is associated with peripheral conjunctivalization and limbal deficiency. Ophthalmology (2006) 0.84
Changing trends in the treatment of dry-eye disease. Expert Opin Investig Drugs (2013) 0.84
Aquaporin 1-positive stromal niche-like cells directly interact with N-cadherin-positive clusters in the basal limbal epithelium. Stem Cell Res (2012) 0.83
Interleukin-4 in patients with prostate cancer. Anticancer Res (2005) 0.83